Standout Papers
Immediate Impact
9 from Science/Nature 58 standout
Citing Papers
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Bipolar disorders
2020 Standout
Works of Bill Kirkpatrick being referenced
Neuropsychology of the Deficit Syndrome: New Data and Meta-analysis of Findings To Date
2006
The NIMH-MATRICS Consensus Statement on Negative Symptoms
2006 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bill Kirkpatrick | 13 | 481 | 1223 | 454 | 18 | 1.5k | |
| Althea M. I. Wagman | 407 | 1076 | 462 | 29 | 1.7k | ||
| Ellen Stover | 444 | 1386 | 396 | 24 | 2.2k | ||
| B. Cornblatt | 490 | 1232 | 316 | 18 | 1.5k | ||
| R.S.E. Keefe | 416 | 1205 | 180 | 23 | 1.5k | ||
| Michael Parrella | 488 | 1322 | 171 | 33 | 1.6k | ||
| W T Carpenter | 493 | 1065 | 252 | 8 | 1.3k | ||
| E. M. Steinmeyer | 612 | 1061 | 227 | 45 | 1.6k | ||
| K.H. Nuechterlein | 514 | 1514 | 376 | 21 | 2.1k | ||
| Kurt Maurer | 592 | 1263 | 248 | 25 | 1.6k | ||
| Markus Heinimaa | 606 | 1453 | 327 | 55 | 1.9k |
All Works
Loading papers...